Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands	6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010
OPERATING ACTIVITIES
Net income including noncontrolling interests	$ 13,788	$ 12,165
Adjustments to reconcile net income including noncontrolling interests to net cash provided by operating activities:
Depreciation and amortization	2,752	2,865
Provision for doubtful accounts	1,128	1,768
Equity-based awards compensation expense	963	578
(Gain) loss on sale of business and sale or abandonment of assets, net	75	(408)
Deferred income tax	950	453
Other	(591)	(162)
Changes in operating assets and liabilities:
Increase in patient accounts receivable	(3,728)	(2,059)
Increase in accounts receivable - other	(1,112)	(234)
Increase in other assets	(1,251)	(401)
Decrease in accounts payable and accrued expenses	(548)	(2,086)
Increase in other liabilities	415	61
Net cash provided by operating activities	12,841	12,540
INVESTING ACTIVITIES
Purchase of fixed assets	(1,484)	(1,588)
Purchase of businesses, net of cash acquired		(8,878)
Acquisitions of noncontrolling interests	(15,885)	(215)
Net proceeds on sale of fixed assets and business	4	895
Net cash used in investing activities	(17,365)	(9,786)
FINANCING ACTIVITIES
Distributions to noncontrolling interests	(4,597)	(4,831)
Cash dividends to shareholders	(1,890)
Proceeds from revolving line of credit	42,300	27,800
Payments on revolving line of credit	(32,000)	(24,600)
Payment of notes payable	(100)	(476)
Excess tax benefit from stock options exercised	622	12
Proceeds from exercise of stock options	2	88
Net cash provided by (used in) financing activities	4,337	(2,007)
Net increase (decrease) in cash	(187)	747
Cash - beginning of period	9,179	6,429
Cash - end of period	8,992	7,176
Cash paid during the period for:
Income taxes	3,367	4,787
Interest	188	115
Non-cash investing and financing transactions during the period:
Purchase of business - seller financing portion		225
Acquisition of noncontrolling interest - seller financing portion	$ 367